Stocktwits on MSN
MNPR stock rallies after hours as experimental drug shows rapid copper balance improvement in genetic disorder
Last week, the company said that it plans to file a New Drug Application with the U.S. Food and Drug Administration in ...
Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, today ...
Copper-Loaded Scaffolds for Targeted Treatment of Traumatic Brain Injury. This illustration shows the process of electrospinning copper oxide-loaded polycaprolactone (PCL) and gelatin (Gel) scaffolds ...
Studies in the roundworm model organism Caenorhabditis elegans, headed by scientists at Florida Atlantic University’s Schmidt College of Medicine and FAU Stiles-Nicholson Brain Institute, have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results